Cerebrospinal Fluid Biomarker Discovery
1. To compare CSF biomarker profiles from healthy individuals and individuals with Alzheimer's Disease and Parkinson's disease.
2. To examine the longitudinal stability of CSF biomarkers in the same subjects.
3. To identify novel CSF biomarkers for use in clinical research.
Alzheimer's Disease, Parkinson's Disease, healthy aging
Age 55-80, willing to complete lumbar puncture, willing to give blood, willing to complete memory testing, must have study partner, not taking Coumadin, Warfarin or other blood thinner.
55 - 90
Healthy Volunteers Needed
Duration of Participation
12 months, 4 visits (last 2 visits optional)
Genevieve Leineweber 503-494-0276 email@example.com
$100 after completion of each lumbar puncture (visits 2, 3 and 4)